3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Sponsor
Interventions
Cisplatin
14
Carboplatin
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
10
Gemcitabine
10
pembrolizumab
8
Pemetrexed
8
atezolizumab
7
Paclitaxel
7
Radiotherapy, Intensity-Modulated
5
Platinum
5
Nivolumab
5
Immunoglobulin G
5
Doxorubicin
5
Docetaxel
5
Disulfides
5
Bevacizumab
5
130-nm albumin-bound paclitaxel
5
1,2-diaminocyclohexaneplatinum II citrate
5
Cetuximab
4
Biopsy
4
durvalumab
3
Temozolomide
3
Standard of Care
3
Rituximab
3
Drug Therapy
3
Dexamethasone
3
Cyclophosphamide
3
(225)Ac-DOTA-c(RGDyK)
3
venetoclax
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Phase 2/3
×
Gefitinib
×
30 days
×
Clear all
No trials found.